Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.

Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.
复制标题

DOI:
10.1371/journal.pone.0038347
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Espinosa L
Espinosa L
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Inglés-Esteve J;Morales M;Dalmases A;Garcia-Carbonell R;Jené-Sanz A;López-Bigas N;Iglesias M;Ruiz-Herguido C;Rovira A;Rojo F;Albanell J;Gomis RR;Bigas A;Espinosa L

文献摘要

参考文献

被引文献

相似文献

14-3-3σ在人类乳腺癌中经常由于基因缺失或启动子甲基化而丢失。我们现在已经研究了14-3-3σ在乳腺细胞中参与NF-κB信号的终止及其在癌症复发和转移中的假定作用。我们的研究结果表明,14-3-3σ调节慢性TNFα刺激后p65-NF-κB的核输出。乳腺癌细胞中14-3-3σ的恢复降低了体内迁移能力和转移能力。通过微阵列分析,我们已经确定了一个基因签名,它以14-3-3σ依赖性方式对TNFα产生反应,并与不同的乳腺癌和其他类型的癌症显著相关。通过查询公共数据库,我们发现这种特征的过度表达与乳腺癌患者的无复发生存率相关。最后,对96例乳腺肿瘤的筛选显示,NF-κB活化与14-3-3σ缺失密切相关,多变量分析显示,NF-κB活化与预后不良显著相关。我们的研究结果确定了一个基因签名,这对乳腺癌预后和未来基于NF-κB靶向的个性化治疗非常重要。
14-3-3σ is frequently lost in human breast cancers by genetic deletion or promoter methylation. We have now investigated the involvement of 14-3-3σ in the termination of NF-κB signal in mammary cells and its putative role in cancer relapse and metastasis. Our results show that 14-3-3σ regulates nuclear export of p65-NF-κB following chronic TNFα stimulation. Restoration of 14-3-3σ in breast cancer cells reduces migration capacity and metastatic abilities in vivo. By microarray analysis, we have identified a genetic signature that responds to TNFα in a 14-3-3σ-dependent manner and significantly associates with different breast and other types of cancer. By interrogating public databases, we have found that over-expression of this signature correlates with poor relapse-free survival in breast cancer patients. Finally, screening of 96 human breast tumors showed that NF-κB activation strictly correlates with the absence of 14-3-3σ and it is significantly associated with worse prognosis in the multivariate analysis. Our findings identify a genetic signature that is important for breast cancer prognosis and for future personalized treatments based on NF-κB targeting.
DOI: 10.1186/gm327
发表时间: 2012-03-29
期刊: Genome medicine
影响因子: 12.3
作者:
Gundem G;Lopez-Bigas N
通讯作者: Lopez-Bigas N
DOI: 10.1073/pnas.0403621101
发表时间: 2004-07-06
影响因子: 11.1
作者:
Biswas, DK;Shi, Q;Iglehart, JD
通讯作者: Iglehart, JD
DOI: 10.1242/jcs.03086
发表时间: 2006-09-01
影响因子: 4
作者:
Aguilera, Cristina;Fernandez-Majada, Vanessa;Espinosa, Lluis
通讯作者: Espinosa, Lluis
DOI: 10.1038/371612a0
发表时间: 1994-10-13
期刊: NATURE
影响因子: 64.8
作者:
FANTL, WJ;MUSLIN, AJ;WILLIAMS, LT
通讯作者: WILLIAMS, LT
Ensembl 2009。
DOI: 10.1093/nar/gkn828
发表时间: 2009-01
影响因子: 14.9
作者:
Hubbard TJ;Aken BL;Ayling S;Ballester B;Beal K;Bragin E;Brent S;Chen Y;Clapham P;Clarke L;Coates G;Fairley S;Fitzgerald S;Fernandez-Banet J;Gordon L;Graf S;Haider S;Hammond M;Holland R;Howe K;Jenkinson A;Johnson N;Kahari A;Keefe D;Keenan S;Kinsella R;Kokocinski F;Kulesha E;Lawson D;Longden I;Megy K;Meidl P;Overduin B;Parker A;Pritchard B;Rios D;Schuster M;Slater G;Smedley D;Spooner W;Spudich G;Trevanion S;Vilella A;Vogel J;White S;Wilder S;Zadissa A;Birney E;Cunningham F;Curwen V;Durbin R;Fernandez-Suarez XM;Herrero J;Kasprzyk A;Proctor G;Smith J;Searle S;Flicek P
通讯作者: Flicek P